Lisa Kays

823 total citations
8 papers, 308 citations indexed

About

Lisa Kays is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lisa Kays has authored 8 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Lisa Kays's work include Cancer Genomics and Diagnostics (3 papers), Immunotherapy and Immune Responses (2 papers) and Chemokine receptors and signaling (2 papers). Lisa Kays is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Immunotherapy and Immune Responses (2 papers) and Chemokine receptors and signaling (2 papers). Lisa Kays collaborates with scholars based in United States, Germany and Canada. Lisa Kays's co-authors include Mark Uhlik, Sheng-Bin Peng, Donald C. Paul, Xiaoyi Zhang, Julie Stewart, John A. Wijsman, Kelly M. Credille, Qi Chen, Maciej J. Zamek‐Gliszczynski and Yu‐Hua Hui and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Lisa Kays

8 papers receiving 304 citations

Peers

Countries citing papers authored by Lisa Kays

Since Specialization

Citations

This map shows the geographic impact of Lisa Kays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Kays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Kays more than expected).

Fields of papers citing papers by Lisa Kays

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Kays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Kays. The network helps show where Lisa Kays may publish in the future.

Co-authorship network of co-authors of Lisa Kays

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Kays. A scholar is included among the top collaborators of Lisa Kays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Kays. Lisa Kays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Abstract 6417: LY3410738, a novel inhibitor of mutant IDH1 is more effective than Ivosidenib and potentiates antileukemic activity of standard chemotherapy in preclinical models of acute myeloid leukemia (AML) 2020 ·Cancer Research ·(unknown), Nathan A. Brooks, Anna Skwarska, Lisa Kays, (unknown), K. David Newell, Kenneth D. Roth, Sandaruwan Geeganage, Raymond Gilmour, Steven M. Chan, Jean‐Emmanuel Sarry, (unknown), Courtney D. DiNardo, Marina Konopleva	6
2	Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1) 2019 ·Cancer Research ·Nathan A. Brooks, (unknown), (unknown), (unknown), Lisa Kays, (unknown), (unknown), John Strelow, (unknown), Kenneth D. Roth, Renato A. Bauer, Stephen Antonysamy, Patric J. Hahn, Zoran Ranković, Denis McCann, Gary Mo, Ramón V. Tiu, Timothy P. Burkholder, Sandaruwan Geeganage, Raymond Gilmour	9
3	Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies 2016 ·PLoS ONE ·Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul, Lisa Kays, Ming Ye, Peter Vaillancourt, Michele Dowless, Louis F. Stancato, Julie Stewart, Mark Uhlik, Haiyan Long, Shaoyou Chu, Victor H. Obungu	50
4	Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells 2015 ·Journal of Biological Chemistry ·Bo Tan, Sucai Dong, Robert L. Shepard, Lisa Kays, Kenneth D. Roth, Sandaruwan Geeganage, Ming‐Shang Kuo, Genshi Zhao	38
5	Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models 2014 ·Molecular Cancer Therapeutics ·Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul, Lisa Kays, Wendy H. Gough, Julie Stewart, Mark Uhlik, Qi Chen, Yu‐Hua Hui, Maciej J. Zamek‐Gliszczynski, John A. Wijsman, Kelly M. Credille, Liang Yan	116
6	Clinical Social Work Practice and Technology: Personal, Practical, Regulatory, and Ethical Considerations for the Twenty-First Century 2014 ·Social Work in Health Care ·(unknown), Lisa Kays, (unknown)	38
7	Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer 2014 ·Investigational New Drugs ·Emiliano Calvo, Victor J. Chen, Mark S. Marshall, U. Ohnmacht, Scott M. Hynes, (unknown), (unknown), Darlene Barnard, Farhana F. Merzoug, Lysiane Huber, Lisa Kays, Philip W. Iversen, Antonio Calles, (unknown), Aimee Bence Lin, Nicolas Dickgreber, Thomas Wehler, Martin Sebastian	47
8	201 Evaluation of the antitumor activity of pemetrexed in combination with the Chk1 inhibitor LY2603618 2010 ·European Journal of Cancer Supplements ·(unknown), Dale L. Barnard, Begoña Díaz, (unknown), Lisa Kays, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact